Notice Information
Notice Title
Community Pharmacy COVID-19 Vaccination Programme Phase 5 2023/24
Notice Description
The National Health Service Commissioning Board (which uses the operational name "NHS England") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. Successful community pharmacies will provide COVID-19 vaccination services under a local enhanced services agreement at designated sites operated by the pharmacies.<br/><br/>Coronavirus " COVID-19 vaccination enhanced service specification for autumn/winter 2022 for community pharmacy (england.nhs.uk)<br/><br/>https://cv19pharmacyeoi.necsu.nhs.uk/
Lot Information
Lot 1
NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme. Community pharmacy has played a critical role in the success of the COVID-19 vaccination programme. Through their strong relationships in local places and neighbourhoods, community pharmacies have helped to tackle vaccine inequalities and improve vaccination take-up.
The fifth phase of the COVID-19 vaccination programme will offer booster (with additional vaccine) for those at the highest risk, to maintain protection against the risk of severe illness, and continue to offer initial vaccinations to those Patients who did not take up or were previously not eligible to receive vaccination in previous phases.
The service will be provided as a Local Enhanced Service (LES) pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. The Community Pharmacy Phase 5 Site Designation Process document sets out the detail of how Pharmacy Contractor can submit expressions of interest for providing the LES and how Pharmacy Contractors who are able to provide the LES will be identified at a regional basis based on site. The LES Agreement document sets out the requirements of service provision. A LES Agreement will be entered into between NHS England and a Pharmacy Contractor selected by NHS England via the Site Designation Process which is set out in the Community Pharmacy Phase 5 Site Designation Process document but only where there is a local population need for additional COVID-19 vaccination services and where NHS England considers the relevant Pharmacy Contractor is best placed to meet that need having applies the criteria, process and steps outlined in the Community Pharmacy Phase 5 Site Designation Process document.
For the avoidance of doubt, this is a voluntary Contract Notice in the interests of achieving maximum transparency and sectoral awareness. NHS England is empowered to facilitate LES Agreements on a site-by-site basis pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.
The items of service payment of PS10.06 per vaccination administered to a Patient.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-03b5c2
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/008617-2023
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85100000 - Health services
85323000 - Community health services
Notice Value(s)
- Tender Value
- £10 Under £100K
- Lots Value
- £10 Under £100K
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 24 Mar 20232 years ago
- Submission Deadline
- 31 Mar 2023Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Janice Brodie
- Contact Email
- janice.brodie@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LEEDS
- Postcode
- LS2 7UE
- Post Town
- Leeds
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- TLE Yorkshire and The Humber
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-03b5c2-2023-03-24T11:27:21Z",
"date": "2023-03-24T11:27:21Z",
"ocid": "ocds-h6vhtk-03b5c2",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-03b5c2",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Community Pharmacy COVID-19 Vaccination Programme Phase 5 2023/24",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"mainProcurementCategory": "services",
"description": "The National Health Service Commissioning Board (which uses the operational name \"NHS England\") is seeking to enter into local enhanced services arrangements with community pharmacies in geographical areas where NHS England identifies there is a need for additional COVID-19 vaccination capacity. Successful community pharmacies will provide COVID-19 vaccination services under a local enhanced services agreement at designated sites operated by the pharmacies.<br/><br/>Coronavirus \" COVID-19 vaccination enhanced service specification for autumn/winter 2022 for community pharmacy (england.nhs.uk)<br/><br/>https://cv19pharmacyeoi.necsu.nhs.uk/",
"value": {
"amount": 10.06,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "NHS is a global leader in achieving high levels of vaccination coverage, and this has been reflected in a hugely successful COVID-19 vaccination programme. Community pharmacy has played a critical role in the success of the COVID-19 vaccination programme. Through their strong relationships in local places and neighbourhoods, community pharmacies have helped to tackle vaccine inequalities and improve vaccination take-up.<br/>The fifth phase of the COVID-19 vaccination programme will offer booster (with additional vaccine) for those at the highest risk, to maintain protection against the risk of severe illness, and continue to offer initial vaccinations to those Patients who did not take up or were previously not eligible to receive vaccination in previous phases.<br/>The service will be provided as a Local Enhanced Service (LES) pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013. The Community Pharmacy Phase 5 Site Designation Process document sets out the detail of how Pharmacy Contractor can submit expressions of interest for providing the LES and how Pharmacy Contractors who are able to provide the LES will be identified at a regional basis based on site. The LES Agreement document sets out the requirements of service provision. A LES Agreement will be entered into between NHS England and a Pharmacy Contractor selected by NHS England via the Site Designation Process which is set out in the Community Pharmacy Phase 5 Site Designation Process document but only where there is a local population need for additional COVID-19 vaccination services and where NHS England considers the relevant Pharmacy Contractor is best placed to meet that need having applies the criteria, process and steps outlined in the Community Pharmacy Phase 5 Site Designation Process document.<br/>For the avoidance of doubt, this is a voluntary Contract Notice in the interests of achieving maximum transparency and sectoral awareness. NHS England is empowered to facilitate LES Agreements on a site-by-site basis pursuant to the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013.<br/>The items of service payment of PS10.06 per vaccination administered to a Patient.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"value": {
"amount": 10.06,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 90
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85323000",
"description": "Community health services"
}
],
"deliveryAddresses": [
{
"region": "UKE"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://health-family.force.com/s/Welcome",
"communication": {
"atypicalToolUrl": "https://health-family.force.com/s/Welcome"
},
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Pursuant to direction 14 of the Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013, NHS England is only authorised to arrange for the provision of an enhanced service with Pharmacy Contractors which are defined as persons included in a list prepared under regulation 10(2)(a) of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2023-03-31T12:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2023-03-31T13:00:00+01:00"
},
"bidOpening": {
"date": "2023-03-31T13:00:00+01:00"
},
"hasRecurrence": true
},
"parties": [
{
"id": "GB-FTS-67205",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "1st Floor, Quarry House, Quarry Hill",
"locality": "Leeds",
"region": "UKE",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Janice Brodie",
"email": "janice.brodie@nhs.net",
"url": "https://health-family.force.com/s/Welcome"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk//",
"buyerProfile": "https://www.england.nhs.uk//",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "NATIONAL_AGENCY",
"description": "National or federal agency/office"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-1661",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "The Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
}
}
],
"buyer": {
"id": "GB-FTS-67205",
"name": "NHS England"
},
"language": "en"
}